News

The discovery partnership spans for an initial period of 3 years, under which Norgine will be provided with a platform to develop multiple targets utilising Jubilant’s integrated drug

Previously, Hari Kumar served as chief business officer of Amira Pharmaceuticals and led the transaction with Bristol-Myers Squibb for the sale of Amira’s fibrosis program. According to the

UshStat was developed using LentiVector platform technology, which is a gene delivery system, with applications in product development and discovery research. The open label, dose escalation Phase I/IIa

Lazanda uses the company’s PecSys drug delivery system, which helps in the rapid absorption of the ingredient across the nasal membrane and directly into the blood stream. The

MultiStem, administered intravenously, is an allogeneic cell therapy product candidate which helps promote healing and tissue repair. The Phase I multi-center dose escalation clinical trial is intended to

The additional studies extended earlier data where BT2111, a conjugate made up of biOasis Transcend vector and trastuzumab (Herceptin), a humanized monoclonal antibody, demonstrated increased ability to kill

The fund will support the translation of life sciences research into early phase drug discovery and development projects. Furthermore, the data packages generated around these projects will show

The facilities will be set up in Obninsk, in Kaluga Oblas and the production is likely to begin in late 2013. The manufacturing process will include entire cycle

CCX168 specifically targets the C5a receptor, a pro-inflammatory mediator that is involved in AAV as well as other autoimmune diseases. The randomized, double-blind, placebo-controlled trial will assess the